Palvella Therapeutics, Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +48.6% | -8.3% | +34.7% | +308.2% | +31.0% | +24.9% | -36.5% | +197.2% | +52.7% | – | |
| – | – | – | +135.5% | +93.2% | -283.7% | – | – | -113.5% | – | -110.7% | – | – | |
| – | -81.2% | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -87.3% | – | |
| – | – | – | – | – | +2,612.7% | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | -75.6% | +3,000.5% | -101.6% | – | -30.7% | -120.2% | – | -99.4% | – | |
| – | – | – | -61.7% | -151.0% | – | -18.9% | -109.2% | – | – | – | -112.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.